Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease

Launched by BEIJING TIANTAN HOSPITAL · Apr 6, 2025

Keywords

ClinConnect Summary

The clinical trial titled "Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease" is focused on better understanding cerebrovascular diseases, which include conditions like strokes. Researchers want to gather information using different imaging techniques, such as CT scans and MRIs, to see how these diseases affect patients and to identify potential new treatments. This study is currently looking for participants between the ages of 18 and 80 who have recently experienced symptoms of a stroke and have been diagnosed through imaging.

To join the study, participants must be able to provide consent and should not have other serious brain conditions or issues that would prevent them from undergoing the imaging tests. If eligible, participants can expect to undergo various imaging tests and contribute to important research that may improve the understanding and treatment of cerebrovascular diseases in the future. Your involvement could help pave the way for better care for others facing similar health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 18 and 80 years old;
• • Onset of symptoms within 7 days;
• • Clinical diagnosis of cerebrovascular disease (ischemic stroke or hemorrhagic stroke) confirmed by head imaging (CT or MRI);
• • Signed informed consent form.
• Exclusion Criteria:
• • Diagnosed with non-cerebrovascular diseases (such as central nervous system infections, epilepsy, and metabolic encephalopathy);
• • Patients with contraindications to multimodal CT or MRI, functional near-infrared imaging, or those who cannot cooperate to complete the relevant examinations;
• • Patients with a life expectancy of less than 3 months or those who cannot complete the study follow-up due to other reasons.